PHARMABIDIOL Trademark

Trademark Overview


On Friday, June 24, 2016, a trademark application was filed for PHARMABIDIOL with the United States Patent and Trademark Office. The USPTO has given the PHARMABIDIOL trademark a serial number of 87083307. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 19, 2018. The PHARMABIDIOL trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and trea...
pharmabidiol

General Information


Serial Number87083307
Word MarkPHARMABIDIOL
Filing DateFriday, June 24, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 19, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2017

Trademark Statements


Goods and ServicesNutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Anti-epileptic pharmaceutical preparations; Dietary and nutritional supplements containing cannabis derivatives, namely, cannabidiol (CBD) oil; Dietary supplements also containing cannabis derivatives, namely, cannabidiol (CBD) oil; Digestives for pharmaceutical purposes; Medicated skin care preparations; Medicated oils containing cannabis derivatives, namely, cannabidiol (CBD) oil; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis, namely, cannabidiol (CBD) oil; Therapeutic pharmaceutical for the treatment of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Therapeutic pharmaceutical for the treatment of inflammation, nausea, convulsions, cancer, anxiety, depression; Therapeutic pharmaceutical for the treatment of Crohns disease, multiple sclerosis, and insomnia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMilwaukee, WI 53212

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMilwaukee, WI 53212

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 19, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 17, 2016UNDELIVERABLE MAIL - COURTESY COPY MAILED
Friday, October 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 7, 2016NON-FINAL ACTION E-MAILED
Friday, October 7, 2016NON-FINAL ACTION WRITTEN
Tuesday, October 4, 2016ASSIGNED TO EXAMINER
Saturday, October 1, 2016ASSIGNED TO EXAMINER
Wednesday, June 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 28, 2016NEW APPLICATION ENTERED IN TRAM